• Loading stock data…

Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate into Proof-of-Concept Clinical Trials

[#item_full_content]

Print Friendly, PDF & Email
Spread the word